NCT06894979 2026-05-15Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine GliomaChildren's Oncology GroupPhase 1 Recruiting54 enrolled